| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| MousePheno | abnormal uterus morphology | 3.42e-05 | 415 | 32 | 7 | MP:0001120 | |
| MousePheno | increased immunoglobulin level | 5.77e-05 | 305 | 32 | 6 | MP:0002461 | |
| MousePheno | increased CD8-positive, alpha-beta T cell number | 7.44e-05 | 195 | 32 | 5 | MP:0008078 | |
| MousePheno | increased IgG level | 8.59e-05 | 201 | 32 | 5 | MP:0002493 | |
| MousePheno | uterus atrophy | 1.81e-04 | 9 | 32 | 2 | MP:0004894 | |
| MousePheno | abnormal vagina epithelium morphology | 1.81e-04 | 9 | 32 | 2 | MP:0001140 | |
| MousePheno | decreased CD8-positive, naive alpha-beta T cell number | 2.23e-04 | 52 | 32 | 3 | MP:0013435 | |
| MousePheno | abnormal IgG level | 2.28e-04 | 392 | 32 | 6 | MP:0020174 | |
| MousePheno | abnormal humoral immune response | 2.34e-04 | 564 | 32 | 7 | MP:0001800 | |
| Domain | VWFA | 6.16e-04 | 82 | 38 | 3 | PS50234 | |
| Domain | VWA | 6.61e-04 | 84 | 38 | 3 | SM00327 | |
| Domain | VWF_A | 1.07e-03 | 99 | 38 | 3 | IPR002035 | |
| Domain | Arm | 1.81e-03 | 31 | 38 | 2 | PF00514 | |
| Domain | TPR | 2.28e-03 | 129 | 38 | 3 | SM00028 | |
| Domain | ARM | 2.99e-03 | 40 | 38 | 2 | SM00185 | |
| Domain | ARM_REPEAT | 2.99e-03 | 40 | 38 | 2 | PS50176 | |
| Domain | Armadillo | 4.11e-03 | 47 | 38 | 2 | IPR000225 | |
| Domain | WD40_repeat_CS | 4.48e-03 | 164 | 38 | 3 | IPR019775 | |
| Domain | VWA | 5.79e-03 | 56 | 38 | 2 | PF00092 | |
| Domain | - | 9.93e-03 | 74 | 38 | 2 | 3.40.50.410 | |
| Domain | - | 1.03e-02 | 222 | 38 | 3 | 1.25.10.10 | |
| Domain | TPR-like_helical_dom | 1.17e-02 | 233 | 38 | 3 | IPR011990 | |
| Pubmed | Ly antigens associated with T cell recognition and effector function. | 6.54e-09 | 4 | 42 | 3 | 6442265 | |
| Pubmed | Ly-C: a third locus specifying alloantigens expressed only on thymocytes and lymphocytes. | 1.42e-06 | 2 | 42 | 2 | 5558567 | |
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 12034498 | ||
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 17096347 | ||
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 3035575 | ||
| Pubmed | Molecular characterization of the murine cytotoxic T-cell membrane glycoprotein Ly-3 (CD8). | 1.42e-06 | 2 | 42 | 2 | 3498943 | |
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 1534146 | ||
| Pubmed | Requirement for CD8 beta chain in positive selection of CD8-lineage T cells. | 1.42e-06 | 2 | 42 | 2 | 8108731 | |
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 24594598 | ||
| Pubmed | Disruption of T lymphocyte positive and negative selection in mice lacking the CD8 beta chain. | 1.42e-06 | 2 | 42 | 2 | 7889415 | |
| Pubmed | Murine Ly-3 restriction fragment length polymorphism and transcript size differences. | 1.42e-06 | 2 | 42 | 2 | 2576243 | |
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 3025647 | ||
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 2452747 | ||
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 9233619 | ||
| Pubmed | Stalk region of beta-chain enhances the coreceptor function of CD8. | 1.42e-06 | 2 | 42 | 2 | 12847256 | |
| Pubmed | The cytoplasmic domain of CD8 beta regulates Lck kinase activation and CD8 T cell development. | 1.42e-06 | 2 | 42 | 2 | 9647223 | |
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 408079 | ||
| Pubmed | Transcriptional diversity at the duplicated human CD8 beta loci. | 1.42e-06 | 2 | 42 | 2 | 8436166 | |
| Pubmed | Lack of inducible nitric oxide synthase promotes intestinal tumorigenesis in the Apc(Min/+) mouse. | 1.42e-06 | 2 | 42 | 2 | 11606502 | |
| Pubmed | Characterization of the mouse CD8 beta chain-encoding gene promoter region. | 1.42e-06 | 2 | 42 | 2 | 8781121 | |
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 3169881 | ||
| Pubmed | The role of NO synthases in arginine-dependent small intestinal and colonic carcinogenesis. | 1.42e-06 | 2 | 42 | 2 | 16329147 | |
| Pubmed | Esr, a second locus in the house mouse controlling esterase-5. | 1.42e-06 | 2 | 42 | 2 | 7103930 | |
| Pubmed | Suppression of intestinal polyposis in Apc(Min/+) mice by inhibiting nitric oxide production. | 1.42e-06 | 2 | 42 | 2 | 11731407 | |
| Pubmed | Repression of PML nuclear body-associated transcription by oxidative stress-activated Bach2. | 1.42e-06 | 2 | 42 | 2 | 15060166 | |
| Pubmed | Molecular linkage of the Ly-3 and Ly-2 genes. Requirement of Ly-2 for Ly-3 surface expression. | 4.27e-06 | 3 | 42 | 2 | 3258885 | |
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 3378837 | ||
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 22081144 | ||
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 1541829 | ||
| Pubmed | Evidence for close linkage of a mouse light chain marker with the Ly-2,3 locus. | 4.27e-06 | 3 | 42 | 2 | 100557 | |
| Pubmed | Zinc is essential for binding of p56(lck) to CD4 and CD8alpha. | 4.27e-06 | 3 | 42 | 2 | 9830036 | |
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 16356863 | ||
| Pubmed | Genetic correlation of a mouse light chain variable region marker with a thymocyte surface antigen. | 4.27e-06 | 3 | 42 | 2 | 4547628 | |
| Pubmed | Linkage of a 7S RNA sequence and kappa light chain genes in the mouse. | 4.27e-06 | 3 | 42 | 2 | 2998983 | |
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 2493728 | ||
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 9218488 | ||
| Pubmed | A new mouse lymphocyte alloantigen (Ly-35) controlled by the Ly-2/3 region on chromosome 6. | 4.27e-06 | 3 | 42 | 2 | 3346044 | |
| Pubmed | LFA-1 knockout inhibited the tumor growth and is correlated with treg cells. | 4.27e-06 | 3 | 42 | 2 | 37723552 | |
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 23311920 | ||
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 12810689 | ||
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 28543390 | ||
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 22893683 | ||
| Pubmed | A CD8 genomic fragment that directs subset-specific expression of CD8 in transgenic mice. | 4.27e-06 | 3 | 42 | 2 | 9126989 | |
| Pubmed | CD8 binding to MHC class I molecules is influenced by T cell maturation and glycosylation. | 4.27e-06 | 3 | 42 | 2 | 11754824 | |
| Pubmed | The synthesis and processing of beta-glucuronidase in normal and egasyn deficient mouse kidney. | 4.27e-06 | 3 | 42 | 2 | 7236294 | |
| Pubmed | Constitutive CD8 expression drives innate CD8+ T-cell differentiation via induction of iNKT2 cells. | 4.27e-06 | 3 | 42 | 2 | 31980555 | |
| Pubmed | An essential role for the stalk region of CD8 beta in the coreceptor function of CD8. | 4.27e-06 | 3 | 42 | 2 | 19109142 | |
| Pubmed | Endobrevin maps to chromosome 2 in human and chromosome 6 in mouse. | 4.27e-06 | 3 | 42 | 2 | 9878266 | |
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 19625641 | ||
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 18929574 | ||
| Pubmed | Recombination between kappa chain genetic markers in the mouse. | 4.27e-06 | 3 | 42 | 2 | 6437974 | |
| Pubmed | Calyculin A inhibits expression of CD8alpha but not CD4 in human peripheral blood T cells. | 4.27e-06 | 3 | 42 | 2 | 11131152 | |
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 10795739 | ||
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 8064243 | ||
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 23741483 | ||
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 24807710 | ||
| Pubmed | CD8beta knockout mice mount normal anti-viral CD8+ T cell responses--but why? | 4.27e-06 | 3 | 42 | 2 | 19088062 | |
| Pubmed | CD8alpha/alpha homodimers fail to function as co-receptor for a CD8-dependent TCR. | 4.27e-06 | 3 | 42 | 2 | 17506031 | |
| Pubmed | Bop: a new T-cell-restricted gene located upstream of and opposite to mouse CD8b. | 4.27e-06 | 3 | 42 | 2 | 7590968 | |
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 11719190 | ||
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 2875941 | ||
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 14568922 | ||
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 9013956 | ||
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 9973530 | ||
| Pubmed | Differential susceptibility of mouse Lyt-2 and Lyt-3 genes to negative regulation. | 4.27e-06 | 3 | 42 | 2 | 8423051 | |
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 2784466 | ||
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 7710778 | ||
| Pubmed | Mapping the binding site on CD8 beta for MHC class I reveals mutants with enhanced binding. | 4.27e-06 | 3 | 42 | 2 | 16951356 | |
| Pubmed | Recombination between kappa chain genetic markers and the Lyt-3 locus. | 4.27e-06 | 3 | 42 | 2 | 6411613 | |
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 15661911 | ||
| Pubmed | 8.53e-06 | 4 | 42 | 2 | 12459555 | ||
| Pubmed | Nitric oxide-mediated regulation of β-amyloid clearance via alterations of MMP-9/TIMP-1. | 8.53e-06 | 4 | 42 | 2 | 23016931 | |
| Pubmed | 8.53e-06 | 4 | 42 | 2 | 24695322 | ||
| Pubmed | 8.53e-06 | 4 | 42 | 2 | 18523287 | ||
| Pubmed | 8.53e-06 | 4 | 42 | 2 | 21115736 | ||
| Pubmed | 8.53e-06 | 4 | 42 | 2 | 16203967 | ||
| Pubmed | 8.53e-06 | 4 | 42 | 2 | 24297179 | ||
| Pubmed | CD8 is needed for development of cytotoxic T cells but not helper T cells. | 8.53e-06 | 4 | 42 | 2 | 1673361 | |
| Pubmed | T cell killing does not require the formation of a stable mature immunological synapse. | 8.53e-06 | 4 | 42 | 2 | 15048111 | |
| Pubmed | CD3 delta establishes a functional link between the T cell receptor and CD8. | 8.53e-06 | 4 | 42 | 2 | 12215456 | |
| Pubmed | 8.53e-06 | 4 | 42 | 2 | 8537123 | ||
| Pubmed | 8.53e-06 | 4 | 42 | 2 | 10369133 | ||
| Pubmed | 1.42e-05 | 5 | 42 | 2 | 23575529 | ||
| Pubmed | 1.42e-05 | 5 | 42 | 2 | 9126927 | ||
| Pubmed | Ligand-engaged TCR is triggered by Lck not associated with CD8 coreceptor. | 1.42e-05 | 5 | 42 | 2 | 25427562 | |
| Pubmed | 1.42e-05 | 5 | 42 | 2 | 17082573 | ||
| Pubmed | 1.42e-05 | 5 | 42 | 2 | 25548254 | ||
| Pubmed | 1.42e-05 | 5 | 42 | 2 | 3138071 | ||
| Pubmed | 1.42e-05 | 5 | 42 | 2 | 11403253 | ||
| Pubmed | Chromosomal localization of the genes encoding rat CD4, CD8alpha, and CD8beta. | 1.42e-05 | 5 | 42 | 2 | 8753864 | |
| Pubmed | Sequence and evolution of the human T-cell antigen receptor beta-chain genes. | 2.13e-05 | 6 | 42 | 2 | 3860845 | |
| Pubmed | 2.13e-05 | 6 | 42 | 2 | 16491076 | ||
| Pubmed | 2.13e-05 | 6 | 42 | 2 | 2898504 | ||
| Pubmed | An anchored molecular map of mouse chromosome 6 with an analysis of interference. | 2.13e-05 | 6 | 42 | 2 | 8563173 | |
| Pubmed | 2.13e-05 | 6 | 42 | 2 | 24069263 | ||
| Pubmed | Dissecting the role of retinoic acid receptor isoforms in the CD8 response to infection. | 2.98e-05 | 7 | 42 | 2 | 24610012 | |
| Pubmed | Genetic nomenclature for loci controlling mouse lymphocyte antigens. | 2.98e-05 | 7 | 42 | 2 | 3817907 | |
| Pubmed | Genetic linkage relationships of loci specifying differentiation alloantigens in the mouse. | 2.98e-05 | 7 | 42 | 2 | 5021438 | |
| Pubmed | 2.98e-05 | 7 | 42 | 2 | 8100806 | ||
| Pubmed | Genetic nomenclature for loci controlling surface antigens of mouse hemopoietic cells. | 3.68e-05 | 53 | 42 | 3 | 1431091 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 2.01e-03 | 43 | 28 | 2 | 409 | |
| GeneFamily | WD repeat domain containing | 7.54e-03 | 262 | 28 | 3 | 362 | |
| GeneFamily | Olfactory receptors, family 5 | 1.29e-02 | 112 | 28 | 2 | 152 | |
| CoexpressionAtlas | alpha beta T cells, T.4.Pa.BDC, 4+ 8- BDC+, Pancreas, avg-2 | 2.76e-05 | 328 | 39 | 6 | GSM605756_500 | |
| CoexpressionAtlas | CD positive, CD4 Test CJ, 4+8-B220-, Spleen, avg-2 | 1.53e-04 | 280 | 39 | 5 | GSM404003_500 | |
| CoexpressionAtlas | alpha beta T cells, T.4int8+.Th, 4int 8+ TCRhi, Thymus, avg-3 | 1.78e-04 | 289 | 39 | 5 | GSM399367_500 | |
| CoexpressionAtlas | alpha beta T cells, T.8Mem.Sp, 4- 8+ 25- 44hi 122hi, Spleen, avg-3 | 2.21e-04 | 303 | 39 | 5 | GSM538398_500 | |
| CoexpressionAtlas | alpha beta T cells, T.8Nve.PP, TCRb+ CD8+ CD44low CD62Lhigh, Peyer's Patch, avg-1 | 2.53e-04 | 67 | 39 | 3 | GSM538414_100 | |
| CoexpressionAtlas | alpha beta T cells, T.4.PLN.BDC, 4+ 8- BDC+, Lymph Node, avg-3 | 3.56e-04 | 336 | 39 | 5 | GSM605758_500 | |
| CoexpressionAtlas | alpha beta T cells, T.4.Pa.BDC, 4+ 8- BDC+, Pancreas, avg-2 | 3.96e-04 | 78 | 39 | 3 | GSM605756_100 | |
| CoexpressionAtlas | alpha beta T cells, T.4Mem.LN, TCRb CD44high CD122lo CD4, Lymph Node, avg-3 | 4.18e-04 | 348 | 39 | 5 | GSM538362_500 | |
| CoexpressionAtlas | CD positive, CD4 Test JS, 4+8-B220-, Spleen, avg-3 | 4.82e-04 | 359 | 39 | 5 | GSM404000_500 | |
| CoexpressionAtlas | alpha beta T cells, T.8SP69+.Th, 4- 8+ TCRhi 69+, Thymus, avg-3 | 5.01e-04 | 362 | 39 | 5 | GSM399385_500 | |
| CoexpressionAtlas | alpha beta T cells, T.4SP69+.Th, 4+ 8- TCRhi 69+, Thymus, avg-3 | 5.20e-04 | 365 | 39 | 5 | GSM399376_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#4_top-relative-expression-ranked_100 | 6.12e-04 | 20 | 39 | 2 | gudmap_developingGonad_e18.5_ovary_100_k4 | |
| ToppCell | Healthy_donor-CD8+_T_naive|Healthy_donor / disease group, cell group and cell class (v2) | 5.36e-07 | 169 | 42 | 5 | 66216758e581365f10c2a66714d83a606ad23af0 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_cytokine_secreting_effector_T_cell|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.91e-06 | 139 | 42 | 4 | a542ef99ba57f364ea9707b3119e11f5a240034c | |
| ToppCell | Healthy_donor-CD8+_T_naive|World / disease group, cell group and cell class (v2) | 1.59e-05 | 161 | 42 | 4 | 8a61395af33132783a0a37956c6f821aba5d3b1e | |
| ToppCell | facs-Marrow-Granulocytes-18m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-05 | 163 | 42 | 4 | 7a04192710f55acf5a4681d5f09942358fdb02ff | |
| ToppCell | NS-critical-d_0-4-Myeloid-Monocyte-derived_Macrophage|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.97e-05 | 170 | 42 | 4 | adf73bdc049d508f8873c22539db2ca92052a97b | |
| ToppCell | Healthy_Control-Lymphoid-T-NK|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 2.41e-05 | 179 | 42 | 4 | 4cd0bb3a99f85ff599b4b79a6a9ace3e51f8b296 | |
| ToppCell | COVID-19-T_cells-CD8+_T_cells|COVID-19 / group, cell type (main and fine annotations) | 2.98e-05 | 189 | 42 | 4 | 2c018d6120f65f0b2704b483bc9da1c0984872e3 | |
| ToppCell | COVID-19_Moderate-CD8+_T_naive|World / disease group, cell group and cell class | 3.10e-05 | 191 | 42 | 4 | c3385226915097f47d2f197166fc755227438524 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.17e-05 | 192 | 42 | 4 | 284955fec5103194d416320f41fa4d87c7efc4fb | |
| ToppCell | Fetal_29-31_weeks-Immune-T_lymphocyte-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.17e-05 | 192 | 42 | 4 | 92f141d5ac462f652f405efa73ac6ef751f40ea3 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.17e-05 | 192 | 42 | 4 | 0d3b2b9cd586a4adbc3755563dd50b140227c287 | |
| ToppCell | Fetal_29-31_weeks-Immune-T_lymphocyte|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.17e-05 | 192 | 42 | 4 | 69a2b04f03a1b82d067018379f7b8a116e954040 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.17e-05 | 192 | 42 | 4 | ad2e0f35d50fe4e6977eba8a7a2bd990f6946305 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.17e-05 | 192 | 42 | 4 | 67f50e5b1d449923002dc5b5d0c4d32c523034d3 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.30e-05 | 194 | 42 | 4 | 7c80fd2a70ee737d52738db6ad58577a15677fc4 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-CD8+_T_naive|COVID-19_Severe / Disease group, lineage and cell class | 3.30e-05 | 194 | 42 | 4 | 6aeedfdb2b526913937eea978ddcbab8be4e49a6 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.30e-05 | 194 | 42 | 4 | a1fabd408a74c2649a69e57e8865b79fdfe9047f | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.30e-05 | 194 | 42 | 4 | 3844ef71804feef04948ff82fec4244e88fb63b2 | |
| ToppCell | Adult-Immune-T_lymphocyte-D231|Adult / Lineage, Cell type, age group and donor | 3.30e-05 | 194 | 42 | 4 | 5c1dca33f382f37a7deb23e573578343c3b54986 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.30e-05 | 194 | 42 | 4 | 1154625adeafa354d8cc847e26b75f4f37e4c39f | |
| ToppCell | T_cells-GZMK+GZMB+_T_cells|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 3.43e-05 | 196 | 42 | 4 | b237287def04def371191b054a41ec0b3150da75 | |
| ToppCell | (22)_CD8+_T_cell|World / immune cells in Peripheral Blood (logTPM normalization) | 3.64e-05 | 199 | 42 | 4 | e1261507f0adade3ba534d5b465c9c559fc3aed0 | |
| ToppCell | VE-CD8-CD8_2|VE / Condition, Cell_class and T cell subcluster | 3.64e-05 | 199 | 42 | 4 | 014fff8a0ebfda094a6ad76ddc0131e12a313394 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Lrg1_(Lrg1)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 8.97e-05 | 92 | 42 | 3 | ed282f0f3da1593bdec5a2b20af5b8f058574167 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Lrg1_(Lrg1)--|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 8.97e-05 | 92 | 42 | 3 | c5f30d58f235f7a72dfe63f58999c4680502576f | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Lrg1_(Lrg1)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 8.97e-05 | 92 | 42 | 3 | 27072dbf6819dca41e41267dc250abfaaf175b2f | |
| ToppCell | Entopeduncular-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Myoc_(Myoc)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.33e-04 | 105 | 42 | 3 | bfd3395c51a0e868aa92eac4e929de59a3fe8b50 | |
| ToppCell | Entopeduncular-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Myoc_(Myoc)--|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.33e-04 | 105 | 42 | 3 | 96566c83999aa625c84a4ed18a6df9daa99f9578 | |
| ToppCell | Entopeduncular-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Myoc_(Myoc)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.33e-04 | 105 | 42 | 3 | 76b73bc9236030e0703868fa8f7ecee2affe565b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.36e-04 | 144 | 42 | 3 | ea174487f8ade90deb33b964a7f7e65062606565 | |
| ToppCell | Control-Lymphocytic_NKT-T_cells-iNKT-MAIT|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.86e-04 | 151 | 42 | 3 | 7e5e35ce601ca3d3722063566e89664909171b8d | |
| ToppCell | COVID-19_Severe-CD8+_T_naive|COVID-19_Severe / disease group, cell group and cell class | 3.94e-04 | 152 | 42 | 3 | e6dbf20504c4fb73d1084b587e040855335b8959 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.09e-04 | 154 | 42 | 3 | 692eb053620db86d301b09bf743ab45fccc245be | |
| ToppCell | COVID-19_Severe-CD8+_T_naive|World / disease group, cell group and cell class | 4.09e-04 | 154 | 42 | 3 | b568417d88a78d8c46688847f0f5f4989bd36387 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.33e-04 | 157 | 42 | 3 | 410c9d74a2085179cfb39853cb6d330fa98c9c1b | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-1|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.41e-04 | 158 | 42 | 3 | cf1b77abd05f18526679c0d305b4dd2caef2b306 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c06-TNF|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.58e-04 | 160 | 42 | 3 | 1a9329d8183296f36928bd9e96f10db9f04ce326 | |
| ToppCell | Healthy/Control-CD8+_T_naive|Healthy/Control / Disease group and Cell class | 4.58e-04 | 160 | 42 | 3 | e1386c21fcbbf57fa32d8bdfba3cb1887477ff73 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c06-TNF|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.66e-04 | 161 | 42 | 3 | a480107b1c7773f2081afca2657e0b7fc88a5645 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-NK_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.75e-04 | 162 | 42 | 3 | 5731f9514434296132df4bc86f78ce87b07cdeca | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-Natural_Killer|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.75e-04 | 162 | 42 | 3 | 0321fc954ae4ad67ca438cbbc84632562d222188 | |
| ToppCell | droplet-Fat-Scat-18m-Lymphocytic-T_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.83e-04 | 163 | 42 | 3 | b1a38985d0560dbc6ca66f711d52a208303860ca | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal-Deuterosomal_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.92e-04 | 164 | 42 | 3 | d9531848105d606adedde65426177cf851140e31 | |
| ToppCell | facs-MAT-Fat-24m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.92e-04 | 164 | 42 | 3 | e9e34c305c943675688e54ab331c2bdefb2fac68 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L3_RORB_CARTPT|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.01e-04 | 165 | 42 | 3 | 00c1d9fce3a017d05ec02133e56be371ab2148f1 | |
| ToppCell | Bronchial_Brush-Epithelial-Goblet_2|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.09e-04 | 166 | 42 | 3 | 8ac0a769be886d16642e7e6334471ebadd1a426b | |
| ToppCell | normal_Lung-Myeloid_cells-CD163+CD14+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 5.09e-04 | 166 | 42 | 3 | 07b498eb341abec02a3ccaae320bdbb5cd6883c5 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.18e-04 | 167 | 42 | 3 | abc4ba308ca3be41b0da604f5d82579fd58dff7b | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.37e-04 | 169 | 42 | 3 | 20fbf78382fb0ba9a63ab1aa0abc615476994ac5 | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD8-Trm_gut_CD8|Lung / Manually curated celltypes from each tissue | 5.55e-04 | 171 | 42 | 3 | c8ccb7795ce8321739e3bc07db2ffc183d04e660 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Lymphocytic-T_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.55e-04 | 171 | 42 | 3 | 4198e7fef1aaee3d85722094f3e444655d393e9e | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Lymphocytic|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.65e-04 | 172 | 42 | 3 | a3bcf0d432d8fccce50248e8d0c7a4804d69bfee | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Lymphocytic-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.65e-04 | 172 | 42 | 3 | 976d27edd5608616830624907fe050fcd3551865 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Lymphocytic-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.74e-04 | 173 | 42 | 3 | de124fb7ded04664d4184bf12f1f201c0784f07c | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-1|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 5.74e-04 | 173 | 42 | 3 | 5d3c917e4d0de3158550a8ab2006ddfa87159ffa | |
| ToppCell | (2)_NK/T-(23)_CD4+_T_cell-(232)_CD4+/CD45RA+_Naive_T_cell|(23)_CD4+_T_cell / immune cells in Peripheral Blood (logTPM normalization) | 5.94e-04 | 175 | 42 | 3 | fc40fda0fb9954cb0970c6ac71f6d6df7d27dc5c | |
| ToppCell | CTRL-Lymphoid-T_cell_&_NK_cell|CTRL / Disease state, Lineage and Cell class | 6.14e-04 | 177 | 42 | 3 | e73d8e78a96b63e27a8a7694c62b3c44ec7ecfe6 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.14e-04 | 177 | 42 | 3 | 8b003ed7887479c3a010ef37dd981b748256bda7 | |
| ToppCell | 3'_v3|World / Manually curated celltypes from each tissue | 6.24e-04 | 178 | 42 | 3 | 42502f14d9c756df8104900ac6484477b885d3d9 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.24e-04 | 178 | 42 | 3 | 5d6297f34e104bacefb25c4e2338b50fe13dd19a | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_neutrophil-granulo-eo/baso/mast-eosinophil|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.34e-04 | 179 | 42 | 3 | d16dc58b5b22762a5a3c875563ced18022d08908 | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.45e-04 | 180 | 42 | 3 | e5bbd0e204da4f98254e3484b383ec1c277b4209 | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.45e-04 | 180 | 42 | 3 | b51b10781082bc0305ba6a81e978729b329f7771 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Epithelial-epithelial_progenitor_cell-Stem_cells|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.55e-04 | 181 | 42 | 3 | c7a220891567c7539ad5a9ac9db375f0de08ea00 | |
| ToppCell | Healthy-CD8+_T_naive|World / disease group, cell group and cell class | 6.66e-04 | 182 | 42 | 3 | b7d9f02c29c92c8803e11f967ad6eea032cb4224 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.66e-04 | 182 | 42 | 3 | 14a117c5e50db31ee1b2cf4df4d133451fd6d55f | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_T_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.66e-04 | 182 | 42 | 3 | 8b8fd33e539e7e253c022481100223b17b279a73 | |
| ToppCell | facs-GAT-Fat-24m-Lymphocytic|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.76e-04 | 183 | 42 | 3 | 377c2c6fcb2fd41396dd7a7a90e9d7ccafccf2f0 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-1|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 6.76e-04 | 183 | 42 | 3 | 06e4b05d86a7d643569e19575c2c9aa351d33f29 | |
| ToppCell | normal-na-Lymphocytic_T-CytoT_GZMK+-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 6.76e-04 | 183 | 42 | 3 | 79defd22b3194dad16db55b9bdd220c09c1e6b90 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4/8-lo-Cycling_T|bone_marrow / Manually curated celltypes from each tissue | 6.76e-04 | 183 | 42 | 3 | a48a6313f2f144586951cece97ec31f6d72361df | |
| ToppCell | Healthy-CD8+_T_naive|Healthy / disease group, cell group and cell class | 6.76e-04 | 183 | 42 | 3 | 5e7a611cfb8a21106bb07361878ccc77ff251502 | |
| ToppCell | facs-GAT-Fat-24m-Lymphocytic-nan|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.76e-04 | 183 | 42 | 3 | f0a6f4f8563491c83fb991b9fb81e75fec7d1ace | |
| ToppCell | COVID-19_Convalescent-Lymphoid_T/NK-CD8+_T_naive|COVID-19_Convalescent / Disease group, lineage and cell class | 6.87e-04 | 184 | 42 | 3 | 0299cd30a3ea8e861a9d529043c204048ae21d29 | |
| ToppCell | remission-CD8+_T_naive|remission / disease stage, cell group and cell class | 6.87e-04 | 184 | 42 | 3 | fe20fa4457d4a4a75689978275b0afb5f6243faf | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.98e-04 | 185 | 42 | 3 | 863a3d44c1f115942d7a2a2b63a92fe5fc768814 | |
| ToppCell | Control-T_cells-CD8+_T_cells|Control / group, cell type (main and fine annotations) | 6.98e-04 | 185 | 42 | 3 | 02ab64c0166c0646d1d4c6ed110ef0b75a1096d0 | |
| ToppCell | COPD-Lymphoid-B|COPD / Disease state, Lineage and Cell class | 6.98e-04 | 185 | 42 | 3 | 925e79c35c381dd44ec5fb921dca09ce43140135 | |
| ToppCell | COVID-19_Convalescent-CD8+_T_naive|COVID-19_Convalescent / Disease condition and Cell class | 6.98e-04 | 185 | 42 | 3 | 2f8277a0b58fb0c49fa76ff6dfa6da961da1f9f5 | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.98e-04 | 185 | 42 | 3 | d4076294571557c223f5b68244e9c53e1d8f0343 | |
| ToppCell | remission-CD8+_T_naive|World / disease stage, cell group and cell class | 6.98e-04 | 185 | 42 | 3 | 69304d7dd406ac7e96d51c239d7035a06d88704f | |
| ToppCell | droplet-Fat-Mat-18m-Lymphocytic-B_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.98e-04 | 185 | 42 | 3 | 98bb853c495eb16c3663685a8e20755bd309b520 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.98e-04 | 185 | 42 | 3 | 27dbfcd40ec832d5cf757331d8af3b5176ae90fb | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.98e-04 | 185 | 42 | 3 | 1c23891e4d75f99296d1304af7a9d6c3cb28d04c | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.98e-04 | 185 | 42 | 3 | ca8e921a6b45cd39474b9f86c95e7be023585c5d | |
| ToppCell | COPD-Lymphoid-B|World / Disease state, Lineage and Cell class | 6.98e-04 | 185 | 42 | 3 | 22891ed75e25ef30dfa541cb82d85e08ce07e7d9 | |
| ToppCell | droplet-Kidney-nan-24m-Lymphocytic-CD45____T_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.09e-04 | 186 | 42 | 3 | 1154a42d0fe18859dc289222a4ef39d1d742d4b4 | |
| ToppCell | Mild-Lymphoid-T-NK|Mild / Condition, Lineage, Cell class and cell subclass | 7.09e-04 | 186 | 42 | 3 | ed37a2df547661d22c1ed0b30cb1c19e489d9d0a | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.09e-04 | 186 | 42 | 3 | 683f59985fbc5d3ba2412c788b4647dbbf42699a | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 7.09e-04 | 186 | 42 | 3 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_B1|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.15e-04 | 42 | 42 | 2 | 09272b388284eba4b6089cef89983ca4b8cd3c90 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.20e-04 | 187 | 42 | 3 | d17352f769c3c66601b65d060626eecff41b0482 | |
| ToppCell | droplet-Kidney-nan-24m-Lymphocytic-T_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.20e-04 | 187 | 42 | 3 | 74fb6cdf2cbd4cb2a29a02ac37839ef7b8ef1593 | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD8-Trm/em_CD8|blood / Manually curated celltypes from each tissue | 7.31e-04 | 188 | 42 | 3 | 21730497f95dc271e4cdfaaf1da8b9ac6eec2ded | |
| ToppCell | mild_COVID-19-CD8+_T_naive|mild_COVID-19 / disease group, cell group and cell class (v2) | 7.31e-04 | 188 | 42 | 3 | 60d27014e5f9e562efe2a602482ea1d07efd0331 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Lymphocytic-T_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.31e-04 | 188 | 42 | 3 | 71ca29203fe1584ff795ad3b34f67e65c3f4daee | |
| ToppCell | mild_COVID-19-CD8+_T_naive|World / disease group, cell group and cell class (v2) | 7.31e-04 | 188 | 42 | 3 | ddfb1c64305825fb0bc23819aa001bfc2ac4c2b2 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.31e-04 | 188 | 42 | 3 | d8decd9b5967873ca8320c2f9f07365f163c777f | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 7.42e-04 | 189 | 42 | 3 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | Control-Lymphoid-T_Cytotoxic|World / Disease state, Lineage and Cell class | 7.42e-04 | 189 | 42 | 3 | ee4c1d930534788a7759d92dc8ff9c62e6ee2301 | |
| Disease | Glioblastoma Multiforme | 1.56e-05 | 111 | 40 | 4 | C1621958 | |
| Disease | Eye Abnormalities | 2.41e-04 | 17 | 40 | 2 | C0015393 | |
| Disease | allergic disease | 4.07e-04 | 258 | 40 | 4 | MONDO_0005271 | |
| Disease | vitronectin measurement | 4.45e-04 | 23 | 40 | 2 | EFO_0021843 | |
| Disease | Drug-Induced Stevens Johnson Syndrome | 7.11e-04 | 29 | 40 | 2 | C1274933 | |
| Disease | Toxic Epidermal Necrolysis | 7.11e-04 | 29 | 40 | 2 | C0014518 | |
| Disease | Mycoplasma-Induced Stevens-Johnson Syndrome | 7.11e-04 | 29 | 40 | 2 | C3658301 | |
| Disease | Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum | 7.11e-04 | 29 | 40 | 2 | C3658302 | |
| Disease | Stevens-Johnson Syndrome | 7.61e-04 | 30 | 40 | 2 | C0038325 | |
| Disease | intellectual disability (is_implicated_in) | 7.61e-04 | 30 | 40 | 2 | DOID:1059 (is_implicated_in) | |
| Disease | allergic rhinitis | 7.83e-04 | 133 | 40 | 3 | EFO_0005854 | |
| Disease | Inflammatory Bowel Diseases | 1.04e-03 | 35 | 40 | 2 | C0021390 | |
| Disease | response to sulfasalazine, Drug-induced agranulocytosis | 1.16e-03 | 37 | 40 | 2 | EFO_0008324, HP_0012235 | |
| Disease | myocardial infarction (biomarker_via_orthology) | 1.33e-03 | 160 | 40 | 3 | DOID:5844 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MASAKMHKELCALMF | 491 | O14727 | |
| MDSETAKMACPRDQM | 171 | Q9BYV9 | |
| AKMRGVLSQAMVMCA | 216 | Q12904 | |
| SGMSMASRLCKAAML | 501 | Q96M93 | |
| SVDMMCRAAKALLAM | 2261 | Q8NFD5 | |
| LELAKCRMDMMSLNS | 486 | Q6ZP65 | |
| TTMMFSMLADCVLKS | 106 | Q2M2E5 | |
| MLACSDTRVKKMAMF | 186 | Q6IEU7 | |
| RRMMAVMSLEVICLA | 716 | Q7Z5J8 | |
| AVLFACMLMRKTMAS | 521 | P35228 | |
| MSMRDCLILVLRKAM | 511 | Q9NVI1 | |
| DDLKEAMNTMMCSRC | 526 | Q6Y2X3 | |
| GVDRADMASLKMMAS | 221 | O15232 | |
| MSLCGARANAKMMAA | 1 | Q9UBE8 | |
| RLCDALMAMDVMLCT | 106 | P21917 | |
| MCSMKRGLDVQMETC | 501 | Q0D2I5 | |
| MVMLSCEAKISLSNM | 36 | A6NJW9 | |
| KACKSMCMWVRAMDL | 2876 | Q9C0G6 | |
| RDCSNKHIKDMMLMS | 531 | Q9Y6J0 | |
| ARIVLMDDAMDCLMS | 121 | Q9H6J7 | |
| MVMLSCEAKISLSNM | 36 | P10966 | |
| AKRMAMLIFTDFLCM | 571 | P23945 | |
| SLIAAIELMKCNMMS | 501 | Q92622 | |
| MLKATSMATMNCLND | 256 | Q9BXB4 | |
| RDLIDKAAMDFCMNM | 581 | Q9HAU5 | |
| MMMKETKECRILCPA | 3391 | O75445 | |
| HGMDLTRDKMCSMVK | 101 | P61247 | |
| MLACSDTRVKKMAMF | 186 | Q8NGP8 | |
| RNMSERSAMAAVLAM | 736 | P29590 | |
| AAATAAIMMMRCARF | 331 | P35237 | |
| TLEMSCKALMRFIMV | 446 | Q86UG4 | |
| LVCRAMCAMMSFEKG | 211 | P49221 | |
| MKDSCITVMAMALLS | 1 | P20701 | |
| KMIAMGSAAALRNLM | 716 | P25054 | |
| MGMTRMLLECSLSDK | 1 | Q6J9G0 | |
| SCVTMERLSHMMERK | 11 | Q3ZCX4 | |
| EMTMCALLAKVQMKA | 56 | Q86TZ1 | |
| RLEESCRAAMMCAMA | 201 | Q8N443 | |
| CRAAMMCAMANANKA | 206 | Q8N443 | |
| MMMDDAVLCMCFSRD | 261 | Q2TAY7 | |
| AMCMNADKLHRARRM | 1151 | Q6P2S7 | |
| SMCVLQCKDMLMRLP | 201 | Q8IYF3 | |
| LEMSMKSACFRMDEQ | 821 | Q9BZH6 | |
| LAMACDDIQRMKADM | 421 | Q5TIE3 |